100s of titles, one news app for just $10 a month.
Dive Deeper:
What 4 Analyst Ratings Have To Say About Enanta Pharmaceuticals
Over the past 3 months, 4 analysts have published their opinion on Enanta Pharmaceuticals (NASDAQ:ENTA) stock. These analysts are typically…
4 Analysts Have This to Say About SITE Centers
Over the past 3 months, 4 analysts have published their opinion on SITE Centers (NYSE:SITC) stock. These analysts are typically…
4 Analysts Have This to Say About TrueCar
TrueCar (NASDAQ:TRUE) has observed the following analyst ratings within the last quarter:
What 4 Analyst Ratings Have To Say About Advantage Solutions
Over the past 3 months, 4 analysts have published their opinion on Advantage Solutions (NASDAQ:ADV) stock. These analysts are typically…
One subscription that gives you access to news from hundreds of sites
4 Analysts Have This to Say About American Express
American Express (NYSE:AXP) has observed the following analyst ratings within the last quarter:
What 4 Analyst Ratings Have To Say About Mercury Systems
Over the past 3 months, 4 analysts have published their opinion on Mercury Systems (NASDAQ:MRCY) stock. These analysts are typically…
Get all your news in one place
Latest Business news:
Travel patterns have changed for good. Transport systems should, too
Enough with all the radii
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
The cryptocurrency sell-off has exposed those swimming naked
And investors are beginning to discriminate
No slump for pump and dump cryptocurrency gangs
Paris (AFP) - In a sleepy corner of the crypto-economy, the value of an obscure coin called Enzyme was tumbling…
ASX slip after rising on tech, US stocks rally on rate rise outlook
Australian shares fall after a positive start on Thursday, following a strong session on Wall Street as investors cling onto…
Apple will finally make deleting your app accounts less of a nightmare
For apps that offer account creation, a new account deletion policy goes into effect at the end of June.
From analysis to good news, read the world’s best news in one place
Pay ‘with a smile or a wave’: Mastercard face recognition system
Mastercard’s “smile to pay” system, announced last week, is supposed to save time for customers at checkouts. It is being…
Power prices to surge up to 18.3 per cent as energy market turmoil flows through to households
Benchmark power prices will rise by up to 18.3 per cent as the energy industry watchdog seeks to pass on…

4 Analysts Have This to Say About Teva Pharmaceutical Indus

By Benzinga Insights

Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 1 2 1 0
Last 30D 0 0 1 0 0
1M Ago 0 0 0 1 0
2M Ago 0 1 0 0 0
3M Ago 0 0 1 0 0

In the last 3 months, 4 analysts have offered 12-month price targets for Teva Pharmaceutical Indus. The company has an average price target of $10.0 with a high of $13.00 and a low of $7.00.

Below is a summary of how these 4 analysts rated Teva Pharmaceutical Indus over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average has decreased by 11.11% from the previous average price target of $11.25.

What Are Analyst Ratings?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
What 4 Analyst Ratings Have To Say About Enanta Pharmaceuticals
Over the past 3 months, 4 analysts have published their opinion on Enanta Pharmaceuticals (NASDAQ:ENTA) stock. These analysts are typically…
4 Analysts Have This to Say About SITE Centers
Over the past 3 months, 4 analysts have published their opinion on SITE Centers (NYSE:SITC) stock. These analysts are typically…
4 Analysts Have This to Say About TrueCar
TrueCar (NASDAQ:TRUE) has observed the following analyst ratings within the last quarter:
What 4 Analyst Ratings Have To Say About Advantage Solutions
Over the past 3 months, 4 analysts have published their opinion on Advantage Solutions (NASDAQ:ADV) stock. These analysts are typically…
One subscription that gives you access to news from hundreds of sites
4 Analysts Have This to Say About American Express
American Express (NYSE:AXP) has observed the following analyst ratings within the last quarter:
What 4 Analyst Ratings Have To Say About Mercury Systems
Over the past 3 months, 4 analysts have published their opinion on Mercury Systems (NASDAQ:MRCY) stock. These analysts are typically…
Get all your news in one place